Key facts
- This page summarizes Ching Jaw's Form 4 filing for CYTOKINETICS INC (CYTK).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 07 Mar 2023, 15:15.
Ching Jaw - 06 Mar 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)
- Reporting relationship
- SVP Finance & CFO
- Issuer ticker
- CYTK
- Reported as of
- 06 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2023, 15:15:17 UTC
- Prior SEC filing
- 03 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Faurescu, attorney-in-fact for Mr. Jaw
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ching Jaw filed Form 4 for CYTOKINETICS INC (CYTK) on 07 Mar 2023.
Change
- Previous filing in this sequence was filed on 03 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +30,000
- Change %
- +52%
- Price
- $0.000000
- Shares after
- 87,346
- Date
- 06 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYTK
transaction
Derivative
Incentive Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +2,555
- Change %
- Price
- $0.000000
- Shares after
- 2,555
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,555
- Exercise price
- $39.13
- Footnotes
- F2
CYTK
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +47,445
- Change %
- Price
- $0.000000
- Shares after
- 47,445
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 47,445
- Exercise price
- $39.13
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
Footnote F2
This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.